NanoString Technologies (NSTG) Receives Media Sentiment Rating of 0.31

Media stories about NanoString Technologies (NASDAQ:NSTG) have been trending positive recently, Alpha One reports. The research group, a unit of Accern, identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real-time. Alpha One ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. NanoString Technologies earned a media sentiment score of 0.31 on Alpha One’s scale. Alpha One also assigned news headlines about the biotechnology company an impact score of 90 out of 100, indicating that recent media coverage is very likely to have an impact on the stock’s share price in the near future.

Insider Buying and Selling by Quarter for NanoString Technologies (NASDAQ:NSTG)

NanoString Technologies (NSTG) traded down 1.9601% during midday trading on Friday, hitting $15.0001. 81,393 shares of the stock traded hands. The stock’s market cap is $325.35 million. The company has a 50-day moving average of $17.53 and a 200-day moving average of $19.15. NanoString Technologies has a 12 month low of $11.89 and a 12 month high of $23.45.

NanoString Technologies (NASDAQ:NSTG) last announced its quarterly earnings results on Thursday, May 4th. The biotechnology company reported ($0.87) earnings per share for the quarter, meeting the consensus estimate of ($0.87). The company had revenue of $18.10 million during the quarter, compared to analysts’ expectations of $17.53 million. NanoString Technologies had a negative return on equity of 6,777.29% and a negative net margin of 57.13%. NanoString Technologies’s quarterly revenue was up 23.1% on a year-over-year basis. During the same period last year, the business earned ($0.74) earnings per share. On average, equities research analysts anticipate that NanoString Technologies will post ($2.51) earnings per share for the current year.

NSTG has been the topic of several research analyst reports. Morgan Stanley cut shares of NanoString Technologies from an “overweight” rating to an “equal weight” rating and lowered their target price for the company from $23.00 to $20.00 in a research note on Thursday, April 20th. ValuEngine upgraded shares of NanoString Technologies from a “sell” rating to a “hold” rating in a research note on Friday, June 2nd. Finally, Zacks Investment Research upgraded shares of NanoString Technologies from a “sell” rating to a “hold” rating in a research note on Wednesday, May 10th.

WARNING: This article was first posted by Mideast Time and is the property of of Mideast Time. If you are viewing this article on another website, it was illegally copied and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this article can be accessed at

About NanoString Technologies

NanoString Technologies, Inc develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:NSTG”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Receive News & Ratings for NanoString Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies Inc. and related companies with's FREE daily email newsletter.

Leave a Reply

© 2006-2017 Mideast Time.